← Open Payments lookup

JAMES KRANTZ: Open Payments

NPI 1801992029 · THURMONT, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,204 in 50 payments from 15 companies in 2025. Trend: 2023 $2,505 · 2024 $2,376 · 2025 $1,204

Food & beverage: $1,204
CompanyPaymentsAmount
Novo Nordisk Inc6$229
AstraZeneca Pharmaceuticals LP9$215
Lilly USA, LLC6$154
Amgen Inc.8$137
GlaxoSmithKline, LLC.4$86
Boehringer Ingelheim Pharmaceuticals, Inc.3$82
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$68
Axsome Therapeutics, Inc.2$50
ABBVIE INC.2$43
Sumitomo Pharma America, Inc.2$34

Products named: AIRSUPRA, Wegovy, JARDIANCE, EVENITY, MOUNJARO, CAPLYTA, TRELEGY ELLIPTA, FARXIGA.

Industry payments across MD — which companies pay providers there.